Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Chlorpyrifos Parkinson’s Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinson’s disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Physical Fitness, Health Should be Factors in Antipsychotic Use: Experts February 21, 2011 Staff Writers Add Your CommentsHealth care providers should take a patient’s physical health and fitness into account when deciding whether to prescribe many popular antipsychotic medications, experts warned in a recently published medical journal article. The major cause of death for patients with severe mental illness is heart disease, often caused by weight gain and diabetes brought on, or exacerbated, by the use of antipsychotic drugs, according to the authors of an editorial in The Lancet medical journal. However, some of the side effects of antipsychotics could be mitigated if doctors and psychiatrists take a more overall look at the patient’s health and factor in diet, physical activity, smoking and other factors.The use of antispychotics such as Seroquel, Zyprexa and Risperdal, have often been associated with weight gain and diabetes.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know About…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONA recent study in the Archives of General Psychiatry found that patients gained 11 to 13 pounds after taking Zyprexa for six to eight weeks. The patients also experienced increases in glucose, cholesterol, triglycerides, and in insulin levels when given a variety of atypical antipsychotics.In light of these new findings and other studies, the editorial writers recommend that mental health care providers assess patients’ physical health when providing mental health care and medications, and take a more active role in patients’ health in conjunction with primary healthcare providers.Atypical antipsychotics generate more than $12 billion in sales every year, with Seroquel leading the pack with nearly $4.45 billion in sales last year.Last week it was reported that AstraZeneca has agreed to pay $350 million to settle Seroquel diabetes lawsuits, which involve claims filed by former users who allege that the drug maker failed to adequately warn about the risk of weight gain and diabetes.As of December, the drug maker had paid $738 million in legal costs associated with Seroquel litigation. The company also paid an additional $520 million last year to settle criminal allegations by the U.S. Department of Justice (DOJ) that it illegally marketed Seroquel for off-label uses.While doctors are free to prescribe approved medications for non-approved uses, drug makers are barred from promoting or encouraging such “off-label” use. Since it was approved, Seroquel has been used by more than 19 million people worldwide, and some people have estimated that at one time as much as 70% of all seroquel prescriptions were for unapproved uses. Tags: Antipsychotics, AstraZeneca, Cholesterol, Diabetes, Heart Disease, Insulin, Risperdal, Seroquel, ZyprexaMore Lawsuit Stories Port Catheter Sepsis Lawsuit Claims Defective SmartPort Implant Caused Infection July 22, 2026 Sapien 3 TAVR Lawsuit Claims Valve Caused Iliac Artery Perforation, Wrongful Death July 22, 2026 Amazon Faces Lawsuit Claiming Defective Telescopic Ladder Caused Severe Injuries July 22, 2026 0 Comments PhoneThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (Posted: yesterday)A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.MORE ABOUT: DUPIXENT LAWSUITDupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026)Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use (06/17/2026)Rezurock Lawsuit Claims GVHD Medication Caused Debilitating Skin Condition, Prurigo Nodularis (06/12/2026) Fourth Uber Driver Sex Assault Lawsuit Bellwether Trial Set for Oct. 2026 (Posted: 2 days ago)A federal judge has scheduled the fourth bellwether trial involving claims that Uber failed to protect passengers from being sexually assaulted by its drivers for early October.MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Faces Investor Lawsuit Over Failure To Stop Driver Sexual Assaults (07/13/2026)Uber Sexual Assault Lawyers To Meet With MDL Judge Next Week, in Advance of Upcoming Trial (06/26/2026)Lyft Rideshare Assault Lawsuit Alleges Company Attempts To Silence Attack Victims (06/15/2026) Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (Posted: 5 days ago)Plaintiffs and defendants have submitted a joint schedule for a final pretrial conference before the second Bard PowerPort lawsuit bellwether trial over claims the port catheter is defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITNew Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)Jury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)
Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (Posted: yesterday)A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.MORE ABOUT: DUPIXENT LAWSUITDupixent MDL Judge To Meet With Lawyers for Initial Case Management Conference in October 2026 (06/25/2026)Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use (06/17/2026)Rezurock Lawsuit Claims GVHD Medication Caused Debilitating Skin Condition, Prurigo Nodularis (06/12/2026)
Fourth Uber Driver Sex Assault Lawsuit Bellwether Trial Set for Oct. 2026 (Posted: 2 days ago)A federal judge has scheduled the fourth bellwether trial involving claims that Uber failed to protect passengers from being sexually assaulted by its drivers for early October.MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITUber Faces Investor Lawsuit Over Failure To Stop Driver Sexual Assaults (07/13/2026)Uber Sexual Assault Lawyers To Meet With MDL Judge Next Week, in Advance of Upcoming Trial (06/26/2026)Lyft Rideshare Assault Lawsuit Alleges Company Attempts To Silence Attack Victims (06/15/2026)
Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (Posted: 5 days ago)Plaintiffs and defendants have submitted a joint schedule for a final pretrial conference before the second Bard PowerPort lawsuit bellwether trial over claims the port catheter is defectively designed.MORE ABOUT: BARD POWERPORT LAWSUITNew Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (05/29/2026)Jury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)